In an exciting announcement in the world of mesothelioma, the immunotherapy drug, Keytruda, has received approval from the Food & Drug Administration (FDA). Keytruda has shown to be effective at controlling mesothelioma tumors in 75% of the patients tested. The drug has been approved for use in patients with advanced non-small cell lung cancer (NSCLC).
By targeting certain proteins necessary to fuel tumors, it is believed that Keytruda can help tumors from growing even larger and then lead to the immune system fighting the tumors naturally.
Keytruda may be an important step toward the FDA-approval of multiple immunotherapy drugs that can be used against mesothelioma tumors.
Mesothelioma is a rare form of cancer caused by the inhalation of asbestos fibers. Asbestos has been used in commercial, residential, and industrial applications for centuries and, therefore, is something that multitudes have been exposed to. If asbestos exposure occurred because of the negligence of a manufacturer or employer, there may be legal recourse against them.
If you or a loved one has mesothelioma and believe it may be due to the negligence of another, please contact our Baltimore mesothelioma lawyers today so that we can help you. We’ve been seeking financial restitution in mesothelioma and asbestos cases for decades and can help your family get the compensation you deserve so you can have the best care possible.
Contact us today for a free case review by calling (410) 625-9330.